A KINDRED with propensity to develop ovarian and other types of cancer has been reported by one of us (H.T.L.) (Lynch et al., 1981) . The inordinately high frequency of individuals with low serum IgA levels (Schuelke et al., 1982) in this kindred is consistent with the numerous observations of altered immune functions associated with ovarian cancer in the general population (Badger et al., 1981; Daunter et al., 1979; Gerber et al., 1977; Hess et al., 1979; Hughes 1971; Humphrey et al., 1977; Mandell et al., 1979; Mantovani et al., 1980a, b; Mikulski et al., 1977; Pattillo et al., 1979a, b; Poulton et al., 1978; Ueda et al., 1978 Ueda et al., , 1979 . We here report the results of tests relative to cellular immune functions in this kindred.
Informed consent was obtained before blood was taken from kindred members and control population donors who resided near this midwestern kindred. Lymphocytes were isolated and stimulated with mitogens in microculture as previously reported (Chaperon, 1982) except that: (1) the base medium was RPMI 1640 (Grand Island Biological Co., Grand Island, NY, U.S.A., and (2) in some cultures, the foetal calf serum was replaced with serum autologous to the lymphocyte donor. The ability of subjects' sera to inhibit antibody-dependent cellular cytotoxicity (ADCC) of chicken red blood cells and natural killer (NK) of K562 cells by normal donor lymphocytes was assessed by a 5ICr (New England Nuclear Corp., Boston, MA, U.S.A.) release assay. Assays were modified from standard methods (Garovoy & Carpenter, 1980 (Schuelke et al., 1982) .
Nineteen individuals represented in Table I and the Figure had intrinsically low blastogenic responses to one or more mitogen when cultured in media containing FCS. Three of the 4 living cancer-patients (III-9, 111-29, had lowered lymphocyte activity several years after cancer surgery. Benign breast disease in Individual 111-39 and advanced age (74 years) in Individual The probabilities of randomly selecting a population with the observed number or a more extreme number of individuals below the normal ranges were calculated to be P --0001, P 0-014 and P 2 x 10-8 for Con-A, PHA, and PWM respectively. Table II and the Figure show that sera from 12 subjects caused a lower blastogenic response to one or more mitogen, even though the most common observation was unchanged or increased responsiveness. This suppressive activity was evident in one cancer patient (111-9), whose serum suppressed the responses of all 3 mitogens. Inhibitory activity(ies) were also present in 2 spouses (111-39, III-50). The most common selective suppression was of Con-A responses (111-36, III-48, 111-50, IV-9, IV-22, IV-35), followed by PHA (111-20, 111-28, IV-17), while selective PWM suppression was not observed. A sex-influenced trend for females preferentially to express serum-mediated mitogenic suppression is suggested by the (111-9, 111-20, 111-50) showed such activity, although the sex ratio of the family members sampled was approximately equal.
Serum-mediated inhibition of NK activity (Table III and the Figure) was presented in 11 bloodline individuals and 2 spouses . NK inhibitory activity occurred both concomitantly with and independently of ADCC suppressor activity, and was present in the 2 cancer patients with lower serum . Sera from 2 apparently well generation IV females (IV-13, IV-36) also inhibited NK activity.
The Figure shows 111-22, 111-52, IV-9, IV-32) whose sera inhibited ADCC effector activity. None of these sera had demonstrable antibodies against the effector cells. Inhibitory activity was present in 2 younger generation IV women (IV-9, IV-32). Based on the results of sera samples from 300 midwestern residents without a known ovarian cancer propensity in their families, it was predicted that 1 in 50 sera would be inhibitory. Thus the probability of randomly selecting a population with 8 or more out of 50 individuals having the activity is calculated to be P.-3 2 x 10-4 (Fisher's exact test). Three sera inhibited E-rosette formation by normal donor T lymphocytes . Two sera were from canceraffected individuals (111-9, IV-14) and one was from a spouse (111-39) subsequently proven to have benign breast disease yet who underwent mastectomy. Direct assessment of E-rosette formation by subjects' lymphocytes in the absence of serum failed to reveal any abnormalities not attributable to noncancerous conditions.
No simple association was evident between any single significant abnormal immune finding and blood markers ( (Byers et al., 1975; Dean et al., 1979; Dworsky et al., 1978; Graham-Pole et al., 1976; Guirgis et al., 1978; Hersey et al., 1979) . The following observations are consistent with an association of immune findings with cancer-prone genotype: (1) predominance of mitogen suppressive activity in sera from high-risk females; (2) instances of selective mitogen inhibition by family sera similar to hepatocellular carcinoma sera effects on mitogen responses (Ren & Chan, 1981) and (3) increased frequency of ADCC and/or NK serum inhibitory activity in older generation III individuals and selective inhibition of one killing activity by some sera is strikingly similar to the results of a mouse tumour study (Nair et al., 1980 
